NCT07694453

Brief Summary

The goal of this observational study is to learn whether metabolic inflexibility, which means reduced ability of the body to switch between using fats and sugars for energy, is associated with myocardial injury after non-cardiac surgery (MINS) in adults undergoing major elective abdominal cancer surgery. The main question it aims to answer is: Does pre-operative metabolic inflexibility predict myocardial injury after non-cardiac surgery (MINS) within the first 72 hours after surgery? Participants will continue with their usual surgical care and pre-planned CPET (which can measure metabolic flexibility). As part of the study, participants will:

  • Have additional blood samples taken before and after surgery
  • Have an echocardiogram and, where possible, muscle ultrasound
  • Wear a wrist-worn activity monitor before surgery
  • Have routine clinical and surgical information collected from their medical records
  • Receive a follow-up phone call around 90 days after surgery

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
49mo left

Started Oct 2026

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 25, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 10, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

October 1, 2026

Expected
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2030

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2030

Last Updated

July 14, 2026

Status Verified

July 1, 2026

Enrollment Period

4 years

First QC Date

June 25, 2026

Last Update Submit

July 13, 2026

Conditions

Keywords

MINSmetabolic flexibilityCPETCardiopulmonary Exercise Testingabdominal cancer surgeryPerioperative medicineTroponin

Outcome Measures

Primary Outcomes (1)

  • Development of Myocardial Injury after Non-Cardiac Surgery

    The primary outcome is the number of participants who develop myocardial injury after non-cardiac surgery (MINS) within 72 hours after surgery. MINS means evidence of heart muscle injury after an operation that is not heart surgery. It will be assessed using blood tests for high-sensitivity cardiac troponin I, a protein that is released into the blood when the heart muscle is injured. Blood samples will be taken on postoperative days 1, 2, and 3. Participants will be classified as having MINS if their postoperative troponin result is above the study-defined threshold for myocardial injury and the injury is judged to be related to the perioperative period rather than another clear non-surgical cause.

    From surgery to 72 hours post surgery

Secondary Outcomes (4)

  • Clavien-Dindo Complication Grade

    From surgery to 30 days after surgery

  • Post-Operative Morbidity Survey (POMS)

    Postoperative day 7

  • Length of Hospital Stay

    From surgery up to hospital discharge, an expected average of 7 days after surgery

  • Days Alive and Out of Hospital at 90 Days

    From surgery to 90 days after surgery

Study Arms (1)

Major Abdominal Cancer Surgery Cohort

Adults aged 18 years and over who are scheduled to undergo major elective abdominal cancer surgery and are already referred for routine pre-operative cardiopulmonary exercise testing (CPET). This is an observational cohort study; no study-specific treatment or intervention will be assigned. Participants will continue with their usual surgical and perioperative care. The study will collect additional blood samples, imaging assessments, CPET-derived metabolic data, wearable activity data, and routine clinical information to evaluate whether pre-operative metabolic inflexibility is associated with myocardial injury after non-cardiac surgery.

Other: Pre-operative Metabolic Inflexibility

Interventions

Pre-operative metabolic inflexibility will be assessed as an observational exposure using data from routine pre-operative cardiopulmonary exercise testing (CPET). CPET-derived measures of substrate utilisation, including fat and carbohydrate oxidation, will be used to evaluate the participant's ability to switch between energy sources during physiological stress. Additional blood-based metabolic, immune, and cardiac biomarker analyses may be used to further characterise metabolic phenotype. No treatment, procedure, or clinical management will be assigned or altered by the study.

Major Abdominal Cancer Surgery Cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be selected from patients receiving care at University College London Hospitals and other participating CIPHER-2 network hospitals, including Southampton and Plymouth. Potential participants will be identified through perioperative/pre-operative assessment pathways, including routine cardiopulmonary exercise testing clinics for patients being assessed before major surgery.

You may qualify if:

  • Adults aged 18 or over
  • Scheduled for major elective abdominal cancer surgery with planned overnight admission
  • Scheduled for pre-operative CPET
  • Able to provide written informed consent

You may not qualify if:

  • Less than 18 years old
  • Emergency surgery
  • Unable or unwilling to undergo CPET
  • Pregnancy
  • Active sepsis
  • End-stage organ failure (e.g. on dialysis)
  • Participants without the mental capacity to consent
  • Diagnosis of Type 1 Myocardial Infarction meeting the 4th Universal Definition criteria during the immediate pre-operative period. (Note: Added based on MINS definition context)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood samples will be retained. These may include plasma, serum, and peripheral blood mononuclear cell (PBMC) samples collected before and after surgery.

Study Officials

  • John Whittle, MBBS, PhD

    University College, London

    PRINCIPAL INVESTIGATOR

Central Study Contacts

John Whittle, MBBS, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 25, 2026

First Posted

July 10, 2026

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

October 1, 2030

Study Completion (Estimated)

October 1, 2030

Last Updated

July 14, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be made publicly available. The study involves clinical data and blood-derived biomarker data from patients undergoing cancer surgery, and data sharing is restricted by participant confidentiality, consent, and data protection requirements. Results will be reported in aggregate form so that individual participants cannot be identified.